Clofoctol

Research use only, not for human use.

Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria.

Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria.

Cell Viability Assay Cell Line:Prostate cancer cell lines: LNCaP, DU145, PC3, LAPC4, CWR22Rv1 and C42BConcentration:0-100 μMIncubation Time:72 h Result:Inhibited cell growth with IC50 values ranging from 10 to 15 μM.Cell Viability Assay Cell Line:PC3 Concentration:0, 10 and 20 μM Incubation Time:24 h Result:Induced a G1 arrest.RT-PCRCell Line:PC3 Concentration:0, 5, 10, 15, 20 and 30 μM Incubation Time:24 h Result:Increased the splicing of XBP-1 mRNA in PC3 cells in a dose-dependent manner. Dose-dependently decreased PstI digestion products from XBP-1 mRNA.Western Blot Analysis Cell Line:PC3 Concentration:0, 5, 10, 15, 20, 25 and 30 μM Incubation Time:0, 0.5, 1, 3, 6 and 9 h or 24 h (cell cycle)Result:Dose- and time-dependently increased the level of phosphorylated eIF2α, up-regulated CHOP expression, and increased the expression of BiP. Led to a dose-dependent decrease in the levels of cyclin A and cyclin D1.

Animal Model:Male athymic nude mice (BALB/c, nu/nu-NCr) aged 4–6 weeks, human prostate cancer xenograft modelDosage:175 mg/kg Administration:Intraperitoneal injection, daily for 37 days Result:Significantly inhibited PC3 tumour growth, tumour weight was also reduced by 60%.Animal Model:K18-hACE2 transgenic C57BL/6J mice with SARS-CoV-2 infection Dosage:62.5 mg/kg Administration:Intraperitoneal injection, 1h and 8h post-infection Result:Induced body weight loss, reduced the viral load in the lungs. The expression of transcripts encoding IL-6, TNFα, IL12p40, IFNβ, IFNγ and the interferon-stimulated genes (ISG) Mx1, Ifi44 and ISG15 was markedly reduced.Animal Model:8–10 week-old female C57BL/6J miceDosage:62.5mg/kg Administration:Intraperitoneal injection, once (Pharmacokinetics) Result:Reached concentrations up to 61 μM in the lungs and remained above this level for almost 4h as early as 30 min after injection.

——

Others

Other Targets

Others

Infection

——

37693-01-9

365.35

C21H26Cl2O

>98% (HPLC)

DMSO: 10 mM

CC(C)(C)CC(C)(C)C1=CC(CC2=C(Cl)C=C(Cl)C=C2)=C(O)C=C1

——

(-20℃)

With Ice Pack

≥ 2 years